Author:
Shimokata Tomoya,Ando Yuichi
Reference6 articles.
1. Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial;Pignata;Lancet Oncol,2014
2. Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial;Katsumata;Lancet,2009
3. Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial;Katsumata;Lancet Oncol,2013
4. Carboplatin dosing for adult Japanese patients;Ando;Nagoya J Med Sci,2014
5. Prospective evaluation of pharmacokinetically guided dosing of carboplatin in Japanese patients with cancer;Shimokata;Cancer Sci,2010
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献